Immune Microenvironments and Hepatocyte Growth Factor Signaling Interactions in Breast Cancer Disparities

乳腺癌差异中的免疫微环境和肝细胞生长因子信号传导相互作用

• 批准号: 10708080
• 负责人: Kevin Peter Williams
• 金额: $ 24.85万
• 依托单位: NORTH CAROLINA CENTRAL UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-20 至 2027-05-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10708080
• 关键词: Anthropology; Automobile Driving; Biological; Biological Markers; Black race; Breast; Breast Cancer Patient; Breast Cancer Risk Factor; Breast Cancer cell line; Breast Carcinoma; Cancer Prognosis; Cancerous; Cell Communication; Cells; Cessation of life; Characteristics; Clinical; Collaborations; DNA Repair; Data; Data Set; Deoxyadenosines; Detection; Diagnosis; Disparity; Elements; Etiology; Frequencies; Gene Expression Profile; Gene Expression Profiling; Genes; Genetic; Genetic Polymorphism; Genomic Instability; Goals; Growth Factor Gene; Growth Factor Overexpression; HGF gene; Health Disparities Research; Immune; Immunohistochemistry; In Vitro; Infiltration; Lesion; Location; Malignant Neoplasms; Measures; Mediating; Mediator; Metastatic breast cancer; Methods; Molecular; Mus; Mutagenesis; Mutate; Mutation; Neoplasm Metastasis; Oncogenic; Outcome; Pathogenesis; Pathway interactions; Patient-Focused Outcomes; Patients; Polymorph; Population Heterogeneity; Prognosis; Promoter Regions; Proteins; Publishing; RNA; Race; Research; Resources; Risk; Role; Sampling; Sampling Studies; Signal Pathway; Signal Transduction; Site; Source; Space Perception; Stromal Cells; Survival Rate; Techniques; Testing; Therapeutic; Tissues; Transfection; Translating; Tumor Subtype; Woman; age related; aggressive breast cancer; black women; breast cancer progression; cancer diagnosis; cancer health disparity; cancer subtypes; cancer type; cell type; comparative; complex data; defined contribution; digital; driving force; effective therapy; epidemiology study; ethnic diversity; experimental study; genetic signature; hormone receptor-negative; immunological status; in vivo; inflammatory breast cancer; innovation; malignant breast neoplasm; mortality; nano-string; neoplastic cell; novel; novel strategies; novel therapeutic intervention; outcome disparities; patient subsets; prognostic; programs; promoter; receptor; social; spatial relationship; stemness; targeted treatment; tool; transcriptome sequencing; tumor; tumor growth; tumor heterogeneity; tumor microenvironment; tumor-immune system interactions; tumorigenesis; wound healing

PROJECT SUMMARY / ABSTRACT – Project 1 Black women suffer disproportionately from higher mortality rates of breast cancers (BC) compared to White women. A driving force in patient outcome is the type of cancer diagnosis and the available treatment options. We focus on two highly aggressive BC subtypes: the hormone receptor negative basal-like breast cancer (BLBC) and the under-studied and deadly inflammatory breast cancer (IBC). Black women present with higher rates of BLBC vs. White women, and since highly effective therapies are lacking, survival is poor. The NCI states IBC is more common and diagnosed in younger Black women, and is often hormone receptor negative. Clearly a need to conduct more advanced studies into these lethal BCs, and their common themes, is critical for patient survival and understanding disparate outcomes. Many studies assessing differences in BCs in Black women and White women examine tumor characteristics; however, etiologic factors that lead to this disparity remain poorly defined. Our data show Black women have unique immune and stromal cell infiltrate and altered protein levels within normal breast and tumor microenvironments. Our objective is to identify mechanisms involved in the progression of aggressive, metastatic BC in Black women as a consequence of stromal effects at the site of the cancerous lesion. Aim 1 takes advantage of our published studies and pilot expression datasets detailing race and tumor- subtype specific stromal interactions that identified a focused pathway, hepatocyte growth factor (HGF) signaling. We propose to use groundbreaking tools to identify the cell-type specific source, levels, and spatial orientation of our signaling pathway molecules within heterogeneous tumors. We will compare these complex data between Black and White BLBC and IBC tumors. Next, we will measure the expression of an HGF functional polymorphism, which is highly expressed in Black women. This genetic difference likely results in a significantly poorer prognosis and survival rate. These data will define subsets of patients who may benefit the most from HGF/MET therapeutics, as this has been a limiting clinical setback. Aim 2 will then evaluate novel immune signature contributions to IBC pathogenesis, and test their association with HGF signaling, race, and poorer outcomes. Aim 3 will use robust experimental studies focused on deregulated DNA repair machineries to elucidate the mechanistic details of the HGF polymorph and its consequence of HGF over-expression. These data will significantly contribute to overcoming our lack of understanding of this highly aggressive IBC and provide a robust signature to identify those at risk for developing IBC. Our team has established research partnerships that provide access to resources including the Carolina Breast Cancer Study: a unique epidemiologic study from ethnically diverse patients. By studying BLBC that has distinct immune/wound healing signatures together with the understudied IBCs, parallels in programs that lead to disparate outcomes may emerge. These pathways will very likely be targetable. The long-term goal of our collaboration is to understand tumor microenvironment interactions and their influence on BC disparities to yield discoveries to be translated and lead to new biomarkers.

项目摘要/摘要 – 项目 1 与白人相比，黑人女性患乳腺癌 (BC) 的死亡率更高 癌症诊断的类型和可用的治疗方案是患者治疗结果的驱动力。 我们专注于两种高度侵袭性 BC 亚型：激素受体阴性基底样乳腺癌 (BLBC) 未经充分研究的致命性炎症性乳腺癌 (IBC) 的发病率较高。 BLBC 与白人女性相比，由于缺乏高效的治疗方法，NCI 指出 IBC 的生存率很差。 在年轻的黑人女性中更常见并被诊断出来，并且通常是激素受体阴性。 对这些致命的 BC 及其共同主题进行更深入的研究对于患者的生存至关重要 许多研究评估黑人女性和白人的 BC 差异。 女性检查肿瘤特征；然而，导致这种差异的病因仍不清楚。 我们的数据显示，黑人女性具有独特的免疫和基质细胞浸润，并改变了体内的蛋白质水平 我们的目标是确定正常乳腺和肿瘤微环境的进展机制。 由于癌变部位的基质效应，导致黑人女性发生侵袭性、转移性 BC 目标 1 利用我们已发表的研究和详细描述种族和肿瘤的试点表达数据集。 亚型特异性基质相互作用确定了一个重点途径：肝细胞生长因子（HGF）信号传导。 我们建议使用突破性的工具来识别细胞类型的特定来源、水平和空间方向 我们将比较这些复杂的数据。 接下来，我们将测量黑色和白色 BLBC 和 IBC 肿瘤的 HGF 功能表达。 多态性在黑人女性中高度表达，这种遗传差异可能导致显着的结果。 这些数据将确定可能从中受益最多的患者亚组。 HGF/MET 疗法，因为这是一个限制性的临床挫折，然后目标 2 将评估新的免疫。 特征对 IBC 发病机制的贡献，并测试它们与 HGF 信号传导、种族和贫困人群的关联 目标 3 将利用针对解除管制的 DNA 修复机制的强有力的实验研究来实现。 阐明 HGF 多晶型物的机制细节及其 HGF 过度表达的后果。 数据将极大地有助于克服我们对这种高度侵略性 IBC 的缺乏了解，并提供 一个强有力的签名来识别那些有发展 IBC 风险的人。我们的团队已经建立了研究合作伙伴关系。 提供资源，包括卡罗莱纳州乳腺癌研究：一项独特的流行病学研究 通过研究具有独特免疫/伤口愈合特征的 BLBC 患者。 在未充分研究的 IBC 中，可能会出现导致不同结果的项目的相似之处。 我们合作的长期目标是了解肿瘤微环境。 相互作用及其对 BC 差异的影响，以产生可转化的发现并产生新的生物标志物。